NI
INO icon

Numeric Investors’s Inovio Pharmaceuticals INO Stock Holding History

Numeric Investors’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1.37M Sell
27,707
-101
-0.4% -$6.26K 0.01% 701
2017
Q3 		$2.12M Buy
+27,808
New +$2.07M 0.02% 585

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Numeric Investors's INO Position: Q4 2017 in Review

Numeric Investors reduced its Inovio Pharmaceuticals (INO) stake by 0.36% in Q4 2017, selling an estimated $6.26K and leaving 27,707 shares worth $1.37M. The position accounts for 0.01% of the portfolio, ranked #701.

Numeric Investors first reported a position in INO in Q3 2017 and has held it in 2 quarters since. The position peaked at $2.12M in Q3 2017. 133 funds tracked by Wall St. Rank hold INO as of Q4 2017.

  • Numeric Investors held 27,707 shares of Inovio Pharmaceuticals worth $1.37M as of Q4 2017.
  • Numeric Investors sold 101 Inovio Pharmaceuticals shares in Q4 2017, an estimated $6.26K.
  • Inovio Pharmaceuticals made up 0.01% of Numeric Investors's portfolio in Q4 2017, its #701 holding.
  • Numeric Investors first reported a position in Inovio Pharmaceuticals in Q3 2017 and has held it in 2 quarters since.
  • Numeric Investors's Inovio Pharmaceuticals position peaked at $2.12M in Q3 2017.
  • 133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.